KR102472612B1 - Method for manufacturing beverage composition using chicken feet and herbal medicine - Google Patents

Method for manufacturing beverage composition using chicken feet and herbal medicine Download PDF

Info

Publication number
KR102472612B1
KR102472612B1 KR1020200048506A KR20200048506A KR102472612B1 KR 102472612 B1 KR102472612 B1 KR 102472612B1 KR 1020200048506 A KR1020200048506 A KR 1020200048506A KR 20200048506 A KR20200048506 A KR 20200048506A KR 102472612 B1 KR102472612 B1 KR 102472612B1
Authority
KR
South Korea
Prior art keywords
chicken feet
weight
extraction
beverage composition
eucommia
Prior art date
Application number
KR1020200048506A
Other languages
Korean (ko)
Other versions
KR20210130383A (en
Inventor
김바오로
김현영
강기성
이기현
백지윤
안창욱
허진주
Original Assignee
주식회사 농업회사법인 성마리오 농장
경상국립대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 농업회사법인 성마리오 농장, 경상국립대학교산학협력단 filed Critical 주식회사 농업회사법인 성마리오 농장
Priority to KR1020200048506A priority Critical patent/KR102472612B1/en
Publication of KR20210130383A publication Critical patent/KR20210130383A/en
Application granted granted Critical
Publication of KR102472612B1 publication Critical patent/KR102472612B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38Other non-alcoholic beverages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L13/00Meat products; Meat meal; Preparation or treatment thereof
    • A23L13/20Meat products; Meat meal; Preparation or treatment thereof from offal, e.g. rinds, skins, marrow, tripes, feet, ears or snouts
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00Products from fruits or vegetables; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • A23L2/60Sweeteners
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/70Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
    • A23L2/72Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L21/00Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
    • A23L21/20Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
    • A23L21/25Honey; Honey substitutes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/14Extraction
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/24Heat, thermal treatment

Abstract

본 발명은 닭발과 한약재를 이용한 음료 조성물의 제조 방법에 관한 것으로서, 더욱 상세히는 닭발과 한약재를 이용하여 항산화 및 항염증 효능을 가지면서 맛과 기호도를 높인 음료 조성물을 제공하기 위한 제조 방법에 관한 것이다. 본 발명은 닭발에 거부감이 있는 사람도 콜라겐을 비롯한 다양한 닭발의 영양 성분을 용이하고 편리하게 음료로서 섭취 가능하도록 제공할 수 있을 뿐만 아니라 닭발에 한약재를 혼합한 후 열수 추출하여 음료 조성물을 제조함으로써 한약재를 통해 맛과 기능성이 향상된 고기능성 제품을 제공할 수 있으며, 이러한 음료 조성물의 섭취를 통해 닭발의 영양 성분과 오가피 및 두충을 포함하는 한약재의 영양 성분에 따른 항산화 활성 및 항염증에 대한 효능을 섭취자에게 제공할 수 있는 효과가 있다.The present invention relates to a method for producing a beverage composition using chicken feet and herbal medicines, and more particularly, to a manufacturing method for providing a beverage composition with improved taste and preference while having antioxidant and anti-inflammatory effects using chicken feet and herbal medicines. . The present invention not only can provide a variety of nutritional components of chicken feet, including collagen, to be easily and conveniently ingested as a beverage by people who are reluctant to chicken feet, but also prepare a beverage composition by mixing herbal medicines with chicken feet and then extracting them with hot water to prepare a beverage composition. Through this, it is possible to provide a high-functional product with improved taste and functionality, and through the intake of such a beverage composition, antioxidant activity and anti-inflammatory effects according to the nutritional components of chicken feet and herbal medicines including cucumber skin and Eucommia are ingested. There is an effect that can be provided to the person.

Description

닭발과 한약재를 이용한 음료 조성물의 제조 방법{Method for manufacturing beverage composition using chicken feet and herbal medicine}Method for manufacturing beverage composition using chicken feet and herbal medicine {Method for manufacturing beverage composition using chicken feet and herbal medicine}

본 발명은 닭발과 한약재를 이용한 음료 조성물의 제조 방법에 관한 것으로서, 더욱 상세히는 닭발과 한약재를 이용하여 항산화 및 항염증 효능을 가지면서 맛과 기호도를 높인 음료 조성물을 제공하기 위한 제조 방법에 관한 것이다.The present invention relates to a method for producing a beverage composition using chicken feet and herbal medicines, and more particularly, to a manufacturing method for providing a beverage composition with improved taste and preference while having antioxidant and anti-inflammatory effects using chicken feet and herbal medicines. .

국민 1인당 닭고기 소비량과 생산량이 증가함에 따라 닭의 부산물도 증가하고 있으며, 이러한 닭의 부산물 중 닭발, 닭똥집, 닭내장 등을 이용한 다양한 식품이 개발되어 제공되고 있다.As the per capita consumption and production of chicken per capita increases, the by-products of chicken are also increasing.

이러한 닭의 부산불 중에서도 닭발은 족발이나 돼지 껍데기와 같이 콜라겐이 많이 함유되어 있는 음식으로 꼽힌다.Among these chicken dishes, chicken feet are regarded as foods that contain a lot of collagen, such as pig's feet or pork skin.

닭발에 포함된 콜라겐은 피부의 재생을 돕고 노화를 방지한다. 또한, 이러한 콜라겐은 연골을 이루는 필수적인 영양분으로 관절과 관련된 질환을 증상을 완화시키고 연골을 강화하는데 도움을 준다.Collagen contained in chicken feet helps skin regeneration and prevents aging. In addition, such collagen is an essential nutrient that forms cartilage, and helps relieve symptoms of joint-related diseases and strengthen cartilage.

또한, 닭발에는 DHA와 EPA 같은 불포화지방산이 풍부하며, 이러한 DHA와 EPA는 두뇌와 성장에 효과적이기 때문에 성장기 어린이와 청소년에게도 좋은 식품이다. In addition, chicken feet are rich in unsaturated fatty acids such as DHA and EPA, and these DHA and EPA are effective for brain and growth, so they are good food for growing children and adolescents.

이밖에도 닭발에는 리놀렌산과 아연이 풍부해 심장병, 당뇨, 고혈압 등각종 성인병 예방에 효과적이며 면역력 강화와 항암효과에도 도움이 된다.In addition, chicken feet are rich in linolenic acid and zinc, which are effective in preventing various adult diseases such as heart disease, diabetes, and high blood pressure, and are also helpful in strengthening immunity and anti-cancer effects.

그러나, 닭발 자체를 자주 섭취하기는 어려울 뿐만 아니라 닭발의 생김새와 맛에 거부감을 가지는 경우가 많아 닭발이 가진 효능을 얻는데 어려움이 있다.However, it is difficult to frequently consume chicken feet themselves, and there are many cases where chicken feet have a reluctance to the appearance and taste of chicken feet, so it is difficult to obtain the efficacy of chicken feet.

따라서, 이러한 닭발의 영양 성분을 편리하게 섭취할 수 있도록 지원하면서 맛과 기호도를 높일 수 있는 건강식품의 개발이 요구되고 있다.Therefore, there is a demand for the development of health foods that can enhance the taste and preference while supporting the convenient intake of nutritional components of these chicken feet.

한국등록특허 제10-1401031호Korean Patent Registration No. 10-1401031

본 발명은 닭발과 한약재를 이용하여 음료로서 섭취할 수 있는 음료 조성물을 제조하여 닭발의 유익한 성분을 편리하게 음료로 섭취할 수 있도록 지원함으로써, 닭발과 한약재의 항산화 및 항염증 효능을 제공할 수 있음과 아울러, 한약재와 다양한 감미료를 통해 맛과 기호도를 높인 음료 조성물을 제공하여 기존의 닭발 섭취에 대한 거부감을 가진 사용자들도 거부감 없이 섭취할 수 있는 음료 조성물을 제공하는데 그 목적이 있다.The present invention manufactures a beverage composition that can be consumed as a beverage using chicken feet and herbal medicines to support the convenient intake of beneficial ingredients of chicken feet as a beverage, thereby providing antioxidant and anti-inflammatory effects of chicken feet and herbal medicines. In addition, the purpose is to provide a beverage composition with improved taste and preference through herbal medicines and various sweeteners, so that users who have a reluctance to eat chicken feet can also consume it without feeling repulsive.

본 발명의 실시예에 따른 닭발과 한약재를 이용한 음료 조성물의 제조 방법은, 닭발의 핏물을 제거하는 제거 단계와, 상기 닭발을 10 ~ 20분간 데치는 데침 단계와, 상기 데침 단계를 거친 닭발, 정제수, 오가피 및 두충을 혼합하여 제조된 혼합물을 열수 추출하여 복합 추출물을 얻는 추출 단계 및 상기 복합 추출물을 여과하여 음료 조성물을 제조하는 여과 단계를 포함할 수 있다.The method for producing a beverage composition using chicken feet and herbal medicines according to an embodiment of the present invention includes a removal step of removing blood from chicken feet, a blanching step of blanching the chicken feet for 10 to 20 minutes, chicken feet after the blanching step, purified water, It may include an extraction step of obtaining a composite extract by hot water extraction of a mixture prepared by mixing cucumber and Eucommia quinoa, and a filtration step of preparing a beverage composition by filtering the composite extract.

본 발명과 관련된 일 예로서, 상기 추출 단계는, 상기 혼합물을 90℃ ~ 110℃에서 10 ~ 20 시간 동안 열수 추출하여 상기 복합 추출물을 얻는 단계인 것을 특징으로 할 수 있다.As an example related to the present invention, the extraction step may be a step of obtaining the composite extract by extracting the mixture with hot water at 90 ° C. to 110 ° C. for 10 to 20 hours.

본 발명과 관련된 일 예로서, 상기 추출 단계는, 상기 혼합물의 전체 중량 비율 중 상기 닭발이 차지하는 중량 비율이 8 ~ 12중량%가 되도록 상기 혼합물을 제조하는 단계를 더 포함하는 것을 특징으로 할 수 있다.As an example related to the present invention, the extraction step may further include preparing the mixture so that the weight ratio of the chicken feet is 8 to 12% by weight of the total weight ratio of the mixture. .

본 발명과 관련된 일 예로서, 상기 추출 단계는, 상기 정제수 70 ~ 80 중량%, 상기 데침 단계를 거친 닭발 8 ~ 12 중량%, 상기 오가피 2 ~ 4 중량%, 상기 두충 2 ~ 4 중량% 및 감미료 6 ~ 10 중량% 혼합하여 상기 혼합물을 제조하는 것을 특징으로 할 수 있다.As an example related to the present invention, in the extraction step, 70 to 80% by weight of the purified water, 8 to 12% by weight of chicken feet that have undergone the blanching step, 2 to 4% by weight of the cucumber skin, 2 to 4% by weight of the worms, and a sweetener It may be characterized in that the mixture is prepared by mixing 6 to 10% by weight.

본 발명과 관련된 일 예로서, 상기 감미료는 대추, 생강, 옥수수염, 꿀, 오미자액으로 구성되는 것을 특징으로 할 수 있다.As an example related to the present invention, the sweetener may be characterized in that it consists of jujube, ginger, corn salt, honey, and Schizandra chinensis.

본 발명은 닭발에 거부감이 있는 사람도 콜라겐을 비롯한 다양한 닭발의 영양 성분을 용이하고 편리하게 음료로서 섭취 가능하도록 제공할 수 있을 뿐만 아니라 닭발에 한약재를 혼합한 후 열수 추출하여 음료 조성물을 제조함으로써 한약재를 통해 맛과 기능성이 향상된 고기능성 제품을 제공할 수 있으며, 이러한 음료 조성물의 섭취를 통해 닭발의 영양 성분과 오가피 및 두충을 포함하는 한약재의 영양 성분에 따른 항산화 활성 및 항염증에 대한 효능을 섭취자에게 제공할 수 있는 효과가 있다.The present invention not only can provide a variety of nutritional components of chicken feet, including collagen, to be easily and conveniently ingested as a beverage by people who are reluctant to chicken feet, but also prepare a beverage composition by mixing herbal medicines with chicken feet and then extracting them with hot water to prepare a beverage composition. Through this, it is possible to provide a high-functional product with improved taste and functionality, and through the intake of such a beverage composition, antioxidant activity and anti-inflammatory effects according to the nutritional components of chicken feet and herbal medicines including cucumber skin and Eucommia are ingested. There is an effect that can be provided to the person.

또한, 본 발명은 닭발을 이용한 음료 조성물을 제조하여 닭발이 가진 항산화 및 항염증 효능을 가진 닭발 고유의 영양 성분을 닭발 자체에 대한 거부감이 있는 사람도 음료 형태로 편리하고 용이하게 섭취할 수 있도록 지원함과 아울러 닭발의 항산화 및 항염증 효능을 높여주는 한약재를 닭발과 혼합하여 음료 조성물을 제조함으로써, 한약재를 통해 닭발 특유의 냄새를 잡아주어 닭발을 이용한 음료의 기호도를 높이면서 닭발의 항산화 및 항염증 효능을 더욱 높여주는 음료를 제공하는 효과가 있다.In addition, the present invention manufactures a beverage composition using chicken feet, so that even those who have a reluctance to chicken feet themselves can conveniently and easily consume the nutritional components unique to chicken feet, which have antioxidant and anti-inflammatory effects, in the form of a beverage. In addition, by mixing herbal medicines that increase the antioxidant and anti-inflammatory effects of chicken feet with chicken feet to prepare a beverage composition, the herbal medicine captures the unique smell of chicken feet, increasing the preference of drinks using chicken feet, while increasing the antioxidant and anti-inflammatory effects of chicken feet It has the effect of providing a drink that further enhances.

도 1은 본 발명의 실시예에 따른 닭발과 한약재를 이용한 음료 조성물의 제조 방법에 대한 순서도.
도 2 내지 도 10은 본 발명의 실시예에 따른 복합 추출물의 추출 조건을 다리하면서 실험한 실험 결과를 나타낸 도면.
도 11 내지 도 13은 본 발명의 실시예에 사용되는 한약재의 효능을 실험한 실험 결과를 나타낸 도면.
1 is a flow chart of a method for producing a beverage composition using chicken feet and herbal medicines according to an embodiment of the present invention.
2 to 10 are views showing the experimental results of the experiment while bridge the extraction conditions of the complex extract according to an embodiment of the present invention.
11 to 13 are diagrams showing the experimental results of testing the efficacy of herbal medicines used in embodiments of the present invention.

이하, 본 발명의 실시예에 따른 닭발과 한약재를 이용한 음료 조성물의 제조 방법에 대한 상세 실시예를 설명한다.Hereinafter, detailed examples of a method for manufacturing a beverage composition using chicken feet and herbal medicines according to an embodiment of the present invention will be described.

설명에 앞서, 본 발명에서 이용하는 닭발은 닭의 발목 아래에 해당하는 부위로서 닭의 발에서 발톱이 있는 발끝을 절단하고 남은 부위로 구성될 수 있다.Prior to the description, the chicken feet used in the present invention may be composed of the parts remaining after cutting the toes with claws from the chicken feet as a part corresponding to the lower part of the chicken's ankle.

또한, 닭발은 뼈가 얇은 연골의 형태이기 때문에 쉽게 씹히고, 껍질은 콜라겐과 같은 결합조직 단백질이 붙어있어 쫀득쫀득한 식감이 난다.In addition, chicken feet are easily chewed because the bones are in the form of thin cartilage, and the skin has a chewy texture because connective tissue proteins such as collagen are attached.

이러한 닭발은 콜라겐이 풍부하여 피부 미용에 도움이 되며, 콘드로이틴(chondroitin)이라는 성분이 함유되어 있어 관절염을 완화하고 골다공증을 예방하는 것으로 알려져 있다. These chicken feet are rich in collagen, which is helpful for skin beauty, and contains a component called chondroitin, which is known to relieve arthritis and prevent osteoporosis.

또한, 닭발은 두뇌와 성장에 효과적인 DHA와 EPA 같은 불포화지방산이 풍부하고, 리놀렌산과 아연이 풍부해 심장병, 당뇨, 고혈압 등각종 성인병 예방에 효과적이며 면역력 강화와 항암효과를 가진다.In addition, chicken feet are rich in unsaturated fatty acids such as DHA and EPA, which are effective for brain growth and growth, and are rich in linolenic acid and zinc, which are effective in preventing various adult diseases such as heart disease, diabetes, and high blood pressure, and have immunity strengthening and anti-cancer effects.

즉, 닭발은 항산화 효능과 항염증 효능을 제공할 수 있다.That is, chicken feet can provide antioxidant and anti-inflammatory effects.

그러나, 닭발은 닭발 특유의 냄새와 모양으로 인해 특정인에게 섭취에 거부감을 유발시키는 경우가 있다.However, chicken feet may cause a certain person to feel reluctance to eat due to the unique smell and shape of chicken feet.

따라서, 본 발명은 이러한 닭발과 한약재를 혼합한 후 열수 추출을 통해 추출한 추출물로부터 얻은 음료 형태(또는 액기스 형태)의 음료 조성물을 제조하여 제공함으로써, 닭발에 거부감이 있는 사람도 용이하고 편리하게 닭발의 영양 성분을 섭취할 수 있도록 지원할 수 있다.Therefore, the present invention prepares and provides a drink composition in the form of a beverage (or liquid form) obtained from the extract extracted through hot water extraction after mixing the chicken feet and herbal medicines, so that people who are reluctant to chicken feet can easily and conveniently use chicken feet. It can help you get nutrients.

또한, 닭발과 함께 음료 조성물의 제조에 이용되는 상기 한약재로서 오가피와 두충을 사용할 수 있다.In addition, as the herbal medicine used in the preparation of the beverage composition together with chicken feet, it is possible to use the cucumber and Eucommia.

오가피는, 두릅나무과의 오갈피나무(Acanthopanax sessiliflorum Seeman) 또는 동속 식물의 뿌리, 줄기 및 가지의 껍질이다.Ogapi is the bark of the roots, stems and branches of Acanthopanax sessiliflorum Seeman of the Araliaceae family or plants of the same genus.

오가피(五加皮)는 간과 신장의 기운을 보하여 힘줄과 뼈를 튼튼하게 하므로 사지마비, 구련, 허리와 무릎의 연약증상, 하지무력감, 골절상, 타박상, 부종 등에 쓰이고 있으며, 면역증강, 항산화, 항피로, 항고온, 항자극작용, 내분비기능조절, 혈압조절, 항방사능, 해독작용의 효능이 보고되고 있다.Five skins (五加皮) strengthen the tendons and bones by strengthening the liver and kidneys, so they are used for quadriplegia, convulsions, weakness of the waist and knees, weakness of the lower extremities, fractures, bruises, edema, etc. Efficacy of anti-fatigue, anti-high temperature, anti-stimulation, regulation of endocrine function, regulation of blood pressure, anti-radiation, and detoxification has been reported.

또한, 두충(杜仲)은 두충나무과(Family Eucommiaceae) 두충속(genus Eucommia)에 속하는 두충(E. ulmoides Oliv.)의 줄기껍질로 주피를 제거한 것으로서, 혈압강하, 항노화, 콜레스테롤 강하, 항염, 진정, 진통, 면역 조절, 혈액응고, 자궁수축, 항알레르기, 항균작용 등의 효능이 보고되고 있다.In addition, Eucommia is a product obtained by removing the epidermis from the stem bark of E. ulmoides Oliv. belonging to the genus Eucommia of the Eucommiaceae family, reducing blood pressure, anti-aging, lowering cholesterol, anti-inflammation, and soothing. , pain relief, immune regulation, blood coagulation, uterine contraction, anti-allergy, and antibacterial effects have been reported.

상술한 구성을 토대도 도 1을 참고하여 본 발명의 실시예에 따른 닭발과 한약재를 이용한 음료 조성물의 제조 방법을 상세히 설명한다.Referring to Figure 1 based on the above configuration will be described in detail the method of manufacturing a beverage composition using chicken feet and herbal medicines according to an embodiment of the present invention.

도시된 바와 같이, 닭발의 핏물을 제거하는 제거 단계를 수행한다(S1).As shown, a removal step of removing blood from chicken feet is performed (S1).

이때, 준비된 상기 닭발 무게의 3배의 정제수를 가하여 1 ~ 2시간 간격으로 물을 교체하면서 핏물을 제거하는 것이 바람직하다.At this time, it is preferable to remove blood while replacing the water at intervals of 1 to 2 hours by adding purified water three times the weight of the prepared chicken feet.

또는, 상기 닭발을 설탕물에 수침(水浸)하여 핏물을 빼면서(제거하면서) 누린내를 제거할 수 있다.Alternatively, the chicken feet can be immersed in sugar water to remove blood while removing (removing) the smell.

다음, 상기 닭발을 10 ~ 20분간 데치는 데침 단계를 수행한다(S2).Next, a blanching step of blanching the chicken feet for 10 to 20 minutes is performed (S2).

이때, 상기 닭발을 끓는 물에서 15분간 데쳐 물기와 불순물을 제거하는 것이 바람직하다.At this time, it is preferable to boil the chicken feet in boiling water for 15 minutes to remove moisture and impurities.

또한, 상기 데침 단계를 거친 닭발, 정제수, 오가피 및 두충을 혼합하여 제조된 혼합물을 열수 추출하여 복합 추출물을 얻는 추출 단계를 수행한다(S3, S4).In addition, an extraction step of obtaining a composite extract by hot water extraction of the mixture prepared by mixing the blanched chicken feet, purified water, cucumber skin, and Eucommia is performed (S3, S4).

이때, 상기 추출 단계에서, 상기 혼합물을 90℃ ~ 110℃에서 10 ~ 20 시간 동안 열수 추출하여 상기 복합 추출물을 얻는 것이 바람직하다.At this time, in the extraction step, it is preferable to obtain the composite extract by hot water extraction of the mixture at 90 ° C. to 110 ° C. for 10 to 20 hours.

더욱 바람직하게는, 상기 추출 단계에서, 상기 혼합물을 100℃에서 15시간 동안 열수 추출하여 상기 복합 추출물을 얻는 것이 바람직하다.More preferably, in the extraction step, the mixture is subjected to hot water extraction at 100° C. for 15 hours to obtain the composite extract.

또한, 상기 추출 단계에서, 상기 혼합물의 전체 중량 비율 중 상기 닭발이 차지하는 중량 비율이 8 ~ 12중량%가 되도록 상기 혼합물을 제조할 수 있다.In addition, in the extraction step, the mixture can be prepared so that the weight ratio of the chicken feet is 8 to 12% by weight of the total weight ratio of the mixture.

이때, 상기 혼합물의 전체 중량 비율 중 상기 닭발이 차지하는 중량 비율은 10%인 것이 바람직하다.At this time, the weight ratio of the chicken feet to the total weight ratio of the mixture is preferably 10%.

또한, 상기 추출 단계에서, 상기 오가피는 오가피를 분쇄하여 분말화한 오가피 분말로 구성될 수 있고, 상기 두충은 상기 두충을 분쇄하여 분말화한 두충 분말로 구성될 수 있다.In addition, in the extraction step, the Eucommia may be composed of Eucalyptus powder obtained by crushing and powdering the Eucommia cypress, and the Eucommia cypress powder may be composed of Eucommia powder obtained by pulverizing and pulverizing the Eucommia.

또는, 상기 추출 단계에서, 상기 오가피는 오가피 절편으로 구성될 수 있고, 상기 두충은 두충 절편으로 구성될 수 있다.Alternatively, in the extraction step, the oleifera may be composed of eucalyptus segments, and the euworms may be composed of eucalyptus segments.

이후, 상기 복합 추출물을 여과하여 음료 조성물을 제조하는 여과 단계를 수행할 수 있다(S5).Thereafter, a filtration step of preparing a beverage composition by filtering the composite extract may be performed (S5).

또한, 상기 여과 단계 이후 상기 음료 조성물을 살균한 후 충진 포장하여 음료 조성물로 이루어진 음료 제품을 제조할 수 있다(S6).In addition, after the filtration step, the beverage composition may be sterilized and then filled and packaged to produce a beverage product made of the beverage composition (S6).

상술한 구성 중 상기 추출 단계에서, 상기 혼합물 제조시 감미료를 추가할 수 있다.In the extraction step of the above configuration, a sweetener may be added when preparing the mixture.

이에 따라, 상기 추출 단계는, 상기 정제수 70 ~ 80 중량%, 상기 데침 단계를 거친 닭발 8 ~ 12 중량%, 상기 오가피 2 ~ 4 중량%, 상기 두충 2 ~ 4 중량% 및 감미료 6 ~ 10 중량%를 혼합하여 상기 혼합물을 제조하는 단계로서 이루어질 수 있다.Accordingly, in the extraction step, 70 to 80% by weight of the purified water, 8 to 12% by weight of the chicken feet that have undergone the blanching step, 2 to 4% by weight of the cucumber skin, 2 to 4% by weight of the worms, and 6 to 10% by weight of the sweetener It may be made as a step of preparing the mixture by mixing.

이때, 상기 감미료는 대추 3 ~ 6 중량%, 생강 1 ~ 2 중량%, 옥수수염 0.5 ~ 1.5 중량%, 꿀 1 ~ 2 중량%, 오미자액 0.5 ~ 1.5 중량%로 구성될 수 있다.In this case, the sweetener may be composed of 3 to 6% by weight of jujube, 1 to 2% by weight of ginger, 0.5 to 1.5% by weight of corn salt, 1 to 2% by weight of honey, and 0.5 to 1.5% by weight of Schisandra chinensis extract.

상술한 바를 통해, 본 발명은 닭발에 거부감이 있는 사람도 콜라겐을 비롯한 다양한 닭발의 영양 성분을 용이하고 편리하게 음료로서 섭취 가능하도록 제공할 수 있을 뿐만 아니라 닭발에 한약재를 혼합한 후 열수 추출하여 음료 조성물을 제조함으로써 한약재를 통해 맛과 기능성이 향상된 고기능성 제품을 제공할 수 있으며, 이러한 음료 조성물의 섭취시 닭발의 영양 성분과 오가피 및 두충을 포함하는 한약재의 영양 성분에 따른 항산화 활성 및 항염증에 대한 효능을 섭취자에게 제공할 수 있다.Through the foregoing, the present invention can provide various nutrients of chicken feet, including collagen, to be easily and conveniently consumed as a beverage by people who are reluctant to chicken feet, as well as mix herbal medicines with chicken feet and extract hot water to drink By preparing the composition, it is possible to provide a high-functional product with improved taste and functionality through herbal medicine, and when ingesting such a beverage composition, antioxidant activity and anti-inflammation according to the nutritional ingredients of chicken feet and herbal medicine including cucumber skin and Eucommia It can provide benefits to the ingester.

한편, 본 발명의 실시예에 따른 음료 조성물의 제조에 사용되는 복합 추출물의 효능을 검증하기 위해 다양한 실험을 수행하였다.On the other hand, various experiments were performed to verify the efficacy of the composite extract used in the preparation of the beverage composition according to the embodiment of the present invention.

우선, 도 2에 도시된 바와 같이, 닭발함량, 추출시간, 추출온도가 미치는 영향을 검토하여 상기 복합 추출물의 최적 추출조건을 확인하기 위해 80 ~ 120℃에서 닭발 함량을 10 ~ 30%로 조정하여 5 ~ 25시간 추출하는 방식으로 상기 복합 추출물의 추출 조건을 달리하여 실험을 진행하였다.First, as shown in FIG. 2, by examining the effects of chicken feet content, extraction time, and extraction temperature, adjusting the chicken feet content to 10 to 30% at 80 to 120 ° C. to confirm the optimal extraction conditions of the complex extract The experiment was conducted by changing the extraction conditions of the composite extract in a manner of extracting for 5 to 25 hours.

도 3 및 도 4는 상기 복합 추출물의 추출 조건을 달리하여 얻어진 복합 추출물의 항산화 활성 실험 관련 ABTS 라디칼 소거활성을 나타낸 도면이다.3 and 4 are diagrams showing the ABTS radical scavenging activity related to the antioxidant activity test of the composite extract obtained by varying the extraction conditions of the composite extract.

ABTS 라디칼 소거능 측정은 7 mM ABTS 용액에 potassium persulfate를 2.4 mM이 되도록 용해시킨 다음 암실에서 12~16시간 동안 반응시킨 다음 732 nm에서 흡광도가 0.7±0.05가 되도록 증류수로 희석하였다. 이 용액 900㎕에 농도별 시료액을 100㎕ 첨가하여 실온에서 3분간 반응시킨 후 732nm에서 흡광도를 측정하였으며, ABTS 라디칼 소거능은 시료첨가구와 무첨가구의 흡광도 비로 나타내었다.ABTS radical scavenging ability was measured by dissolving potassium persulfate in 7 mM ABTS solution to 2.4 mM, reacting in the dark for 12 to 16 hours, and then diluting with distilled water so that the absorbance at 732 nm was 0.7 ± 0.05. After adding 100 μl of the sample solution for each concentration to 900 μl of this solution, reacting at room temperature for 3 minutes, the absorbance was measured at 732 nm.

도 3에 도시된 바와 같이, ABTS 라디칼 소거활성은 추출물 농도 50 mg/ml 처리 시 닭발함량 10%, 20% 및 30%에서 각각 95.59%, 81.18% 및 70.53%의 라디칼 소거활성을 나타내어 닭발 함량 10%에서 가장 높은 활성을 나타내었으며, 전체적으로 추출물 처리 농도가 감소함에 따라 라디칼 소거활성 또한 유의적으로 감소하는 패턴을 나타내었다.As shown in FIG. 3, the ABTS radical scavenging activity showed 95.59%, 81.18%, and 70.53% of the radical scavenging activity at 10%, 20%, and 30% chicken feet content, respectively, when the extract concentration was 50 mg/ml. It showed the highest activity in %, and the radical scavenging activity also showed a pattern of significantly decreasing as the concentration of the extract treatment decreased overall.

또한, 도 4에 도시된 바와 같이, 추출물 농도 50 mg/ml 처리 시 추출온도 80℃, 100℃ 및 120℃에서 각각 76.57%, 95.59% 및 76.86%의 라디칼 소거활성을 나타내어 추출온도 100℃에서 가장 높은 활성을 나타내었으며, 전체적으로 추출물 처리 농도가 감소함에 따라 라디칼 소거활성 또한 유의적으로 감소하는 패턴을 나타내었다.In addition, as shown in FIG. 4, when the extract concentration was 50 mg/ml, the radical scavenging activity was 76.57%, 95.59%, and 76.86% at extraction temperatures of 80 ° C, 100 ° C, and 120 ° C, respectively, and the highest at 100 ° C. It showed high activity, and as the overall concentration of the extract treatment decreased, the radical scavenging activity also showed a pattern of significantly decreasing.

도 5는 상기 복합 추출물의 추출 조건 중 추출 시간을 달리하여 얻어진 복합 추출물의 항산화 활성 실험 관련 FRAP(Ferric-reducing antioxidant power) 활성을 나타낸 도면이다.5 is a view showing the antioxidant activity test-related FRAP (Ferric-reducing antioxidant power) activity of the composite extract obtained by varying the extraction time among the extraction conditions of the composite extract.

FRAP에 의한 항산화 활성의 측정은 환원력을 이용한 방법으로 Benzie와 Strain방법(1996)을 응용하여 측정하였다. Reaction solution은 300 mM acetate buffer(pH 3.6), 40 mM HCl에 녹인 10 mM 2,4,6-tris (2-pyridyl)-s-triazine (TPTZ) 및 20 mM iron(Ⅲ) chloride를 10:1:1로 실험직전에 만들어 사용하였다. 시료액 50 ㎕, reaction solution 950 ㎕를 차례로 혼합하여 37℃에서 5분간 반응시킨 후 590 nm에서 흡광도를 측정하였다.Antioxidant activity by FRAP was measured by applying the Benzie and Strain method (1996) as a method using reducing power. The reaction solution is a 10:1 ratio of 10 mM 2,4,6-tris (2-pyridyl)-s-triazine (TPTZ) and 20 mM iron(III) chloride dissolved in 300 mM acetate buffer (pH 3.6) and 40 mM HCl. :1 was used immediately before the experiment. 50 μl of the sample solution and 950 μl of the reaction solution were sequentially mixed and reacted at 37° C. for 5 minutes, and the absorbance was measured at 590 nm.

도시된 바와 같이, FRAP 활성의 경우 ABTS 라디칼 소거활성과는 다른 패턴을 보였다. 추출물 농도가 50 mg/g 일 때 각각 0.48(5hr), 0.98(15hr), 0.74(25hr)이었으며, 모든 농도 구간에서 15시간이 가장 높은 활성을 보였다.As shown, the FRAP activity showed a different pattern from the ABTS radical scavenging activity. When the extract concentration was 50 mg/g, it was 0.48 (5 hr), 0.98 (15 hr), and 0.74 (25 hr), respectively, and 15 hours showed the highest activity in all concentration sections.

또한, 추출 조건을 달리한 복합 추출물의 항염증 효능 검증을 세포 실험에서 확인하기 위하여, 마우스 대식세포인 RAW 264.7 세포를 이용하였고, 도 6에 도시된 바와 같은 실험방법을 통하여 세포독성 및 NO(Nitric Oxide) 생성량 활성 실험을 진행하였다.In addition, in order to verify the anti-inflammatory efficacy of the composite extract under different extraction conditions in cell experiments, mouse macrophage RAW 264.7 cells were used, and cytotoxicity and NO (Nitric Oxide) production activity experiment was conducted.

도 7은 상기 복합 추출물 추출 시 닭발 함량 10%와 추출 시간 15시간을 고정으로 하고 추출 온도만 다르게 추출하여 세포독성을 실험한 결과에 대한 도면이다.7 is a view of the results of cytotoxicity experiments by fixing 10% of chicken feet content and 15 hours of extraction time and extracting at different extraction temperatures when extracting the complex extract.

도시된 바와 같이, 닭발 80℃(T1)로 추출하였을 때 1.56 ~ 12.5 mg/ml에서 34.4 ~ 37.1%의 세포독성을 나타냈고, 25 mg/ml에서는 87.5%의 세포생존율을 나타내었다. 50 mg/ml에서는 세포생존율이 122.4%로 가장 높게 나타났지만 이는 고농도 진득한 상태의 누런색 시료 자체색깔로 판단하여 제외하였다. 닭발 100℃(T2)로 추출하였을 때 9 ~ 40 mg/ml에서는 123 ~ 106.7%의 높은 세포생존율을 보였고, 50 mg/ml에서는 86.8%의 세포생존율을 나타내었지만 시료 자체색깔로 판단하여 제외하였다. 120℃(T3)로 추출하였을 때 1.56mg/ml, 3.12 mg/ml에서는 96.5%, 89.9%의 세포생존율을 나타냈지만 6.25 ~ 50 mg/ml에서 69.8 ~ 39.7%로 70% 이하의 세포생존율을 나타내어 세포독성이 있다고 판단하였다.As shown, when extracted with chicken feet at 80 ° C (T1), cytotoxicity was 34.4 to 37.1% at 1.56 to 12.5 mg / ml, and cell viability was 87.5% at 25 mg / ml. At 50 mg / ml, the cell viability was the highest at 122.4%, but this was excluded because it was judged by the color of the yellow sample in a high-concentration thick state. When extracted with chicken feet at 100 ° C (T2), 9 ~ 40 mg / ml showed a high cell viability of 123 ~ 106.7%, and 50 mg / ml showed a cell viability of 86.8%, but it was judged by the color of the sample itself and excluded. When extracted at 120℃ (T3), cell viability was 96.5% and 89.9% at 1.56 mg/ml and 3.12 mg/ml, but 69.8 to 39.7% at 6.25 to 50 mg/ml, showing less than 70% cell viability. It was judged to be cytotoxic.

도 8은 상기 복합 추출물 추출 시 닭발 함량 10%와 추출 시간 15시간을 고정으로 하고 추출 온도만 다르게 추출하여 Nitric Oxide(NO) 생성 억제 효과를 측정한 결과에 대한 도면이다.8 is a view of the results of measuring the effect of inhibiting production of nitric oxide (NO) by fixing 10% of chicken feet content and 15 hours of extraction time and extracting at different extraction temperatures when extracting the complex extract.

도시된 바와 같이, 닭발 80℃(T1)로 추출한 시료에서 LPS 단독 처리군의 nitric oxide 생성량은 37.7μM이고 1.56mg/ml, 3.12mg/ml에서 37.7, 44.9 μM로 억제 효과가 나타나지 않았고 6.25mg/ml, 12.5mg/ml, 25mg/ml, 50mg/ml에서는 31.6μM, 22.9μM, 8.5μM, 23.6μM의 소거능을 보였다. 25 mg/ml에서 가장 높은 소거능을 나타냈다. 100℃(T2)로 추출하였을 때 LPS 단독처리군은 29.3μM인 반면 9 ~ 40 mg/ml에서는 8.5 ~ 28μM의 소거능을 나타냈고 50 mg/ml에서는 30μM로 소거능이 나타나지 않았다. 120℃(T3) 추출 시 LPS 단독처리시 44.8μM로 높았고, 1.56 ~ 25 mg/ml에서 43 ~ 9μM의 소거능을 나타냈다. 50 mg/ml에서는 9.9μM의 소거능을 나타내었지만 세포독성 실험 시 독성을 나타내어 제외하였다. As shown, in the sample extracted from chicken feet at 80 ° C (T1), the amount of nitric oxide produced in the LPS-only treatment group was 37.7 μM, 1.56 mg/ml, 3.12 mg/ml, 37.7, 44.9 μM, and no inhibitory effect was observed, and 6.25 mg/ml At ml, 12.5 mg/ml, 25 mg/ml, and 50 mg/ml, the scavenging activity was 31.6 μM, 22.9 μM, 8.5 μM, and 23.6 μM. The highest scavenging activity was shown at 25 mg/ml. When extracted at 100 ° C (T2), the LPS alone treatment group showed 29.3 μM, while 9 ~ 40 mg / ml showed 8.5 ~ 28 μM of scavenging activity, and 50 mg / ml showed 30 μM of scavenging activity. When extracted at 120℃ (T3), it was as high as 44.8 μM when LPS alone was treated, and showed scavenging ability of 43 to 9 μM at 1.56 to 25 mg/ml. At 50 mg/ml, it showed a scavenging ability of 9.9 μM, but was excluded due to toxicity during cytotoxicity experiments.

도 9는 복합 추추물 추출시 닭발 함량 10%와 추출 온도 100℃를 고정으로 하고 추출 시간만 다르게 하여 세포독성 및 NO(Nitric Oxide) 소거능을 실험한 결과에 대한 도면이다.9 is a view of the results of experiments on cytotoxicity and NO (Nitric Oxide) scavenging ability by fixing 10% of chicken foot content and 100 ° C. of extraction temperature and different extraction times during extraction of complex extracts.

도시된 바와 같이, 닭발 함량 10%와 100℃에서 5시간 추출(H1)하였을 때 세포생존율이 1.56 ~ 12.6 mg/ml에서는 38.6 ~ 55.5%의 세포독성을 나타내었고, 25 mg/ml에서는 85.4%의 생존율을 나타냈다. 50 mg/ml에서는 91.9%의 세포생존율을 나타내었지만 고농도 진득한 상태의 누런색 시료 자체색깔로 판단하여 제외하였다. 닭발 추출을 15시간(H2)로 추출하였을 때 9 ~ 40 mg/ml에서는 123 ~ 106.7%의 높은 세포생존율을 보였고, 50 mg/ml에서는 86.8%의 세포생존율을 나타내었지만 시료 자체색깔로 판단하여 제외하였다. 닭발 추출을 25시간(H3)로 추출하였을 때 1.56 ~ 6.25 mg/ml에서는 101.5 ~ 108.5%로 control보다 높았고, 12.5 mg/ml, 25 mg/ml에서는 98.7%, 84.7%의 생존율을 보였다. 50 mg/ml에서는 32.9%의 세포독성을 나타내었다. Nitric Oxide(NO) 생성 억제 효과를 측정한 결과, 5시간 추출(H1)하였을 때 3.12 ~ 100 mg/ml에서 41.7 ~ 55.4 μM로 LPS 단독처리군의 38.4 μM 보다 높게 나와서 NO 소거능은 없다고 판단하였다. 15시간(H2)로 추출하였을 때 LPS 단독처리군이 29.3 μM에 비해 9, 10 mg/ml에서 8.5, 8.7 μM의 높은 소거능을 보였다. 25시간(H3)로 추출하였을 때 1.56 ~ 50 mg/ml에서 LPS 단독처리군 38.1 μM 보다 높은 50 ~ 34.9 μM을 나타내어 소거활성이 없다고 판단하였다.As shown, when extracting (H1) for 5 hours at 100 ° C with 10% chicken feet content, cell viability was 38.6 to 55.5% at 1.56 to 12.6 mg / ml, and 85.4% at 25 mg / ml. showed the survival rate. At 50 mg/ml, the cell viability was 91.9%, but it was excluded because it was judged by the yellow color of the sample itself in a high-concentration viscous state. When chicken feet were extracted for 15 hours (H2), cell viability was 123 to 106.7% at 9 to 40 mg/ml, and cell viability was 86.8% at 50 mg/ml, but was excluded based on the color of the sample itself. did When chicken feet were extracted for 25 hours (H3), 101.5 to 108.5% at 1.56 to 6.25 mg/ml were higher than the control, and survival rates were 98.7% and 84.7% at 12.5 mg/ml and 25 mg/ml. At 50 mg/ml, cytotoxicity was 32.9%. As a result of measuring the effect of suppressing nitric oxide (NO) production, when extracted for 5 hours (H1), it was 41.7 ~ 55.4 μM at 3.12 ~ 100 mg / ml, higher than 38.4 μM of the LPS alone treatment group, so it was judged that there was no NO scavenging ability. When extracted for 15 hours (H2), the LPS-only group showed higher scavenging efficiencies of 8.5 and 8.7 μM at 9 and 10 mg/ml compared to 29.3 μM. When extracted for 25 hours (H3), it was determined that there was no scavenging activity at 1.56 to 50 mg/ml, as it showed 50 to 34.9 μM, which is higher than 38.1 μM in the LPS alone treatment group.

도 10은 복합 추출물 추출 시 추출 온도 100℃와 15시간 추출 조건을 고정으로 하고 닭발 함량만 다르게 하여 세포독성 및 NO 소거능을 실험한 결과에 대한 도면이다.10 is a diagram of the results of experiments on cytotoxicity and NO scavenging ability by fixing the extraction temperature of 100 ° C. and 15-hour extraction conditions and varying only the chicken foot content during extraction of the composite extract.

닭발 함량 10%(C1)로 추출하였을 때 9 ~ 40 mg/ml에서는 123 ~ 106.7%의 높은 세포생존율을 보였고, 50 mg/ml에서는 86.8%의 세포생존율을 나타내었지만 시료 자체색깔로 판단하여 제외하였다. NO 소거능에서 LPS 단독처리군이 29.3 μM에 비해 9 mg/ml, 10 mg/ml에서 8.5μM, 8.7μM의 높은 소거능을 보여 소거활성이 높다고 판단하였다. 닭발 함량 20%(C2)로 추출하였을 때 1.56 ~ 50 mg/ml에서 45.4 ~ 67.1%의 세포 독성을 나타내었고, NO 소거능이 1.56 ~ 50 mg/ml에서 41.5 ~ 77.8 μM로 LPS 단독처리군 37.7 μM보다 높은 NO 생성량으로 소거활성이 없었다. 닭발 함량 30%(C3)로 추출하였을 때 9 ~ 50 mg/ml에서 45.8 ~ 61.7% 생존율로 세포독성을 나타내었고, 1.25 ~ 10 mg/ml에서 37.8 ~ 37.4 μM로 LPS 단독처리군 43.6 μM에 비해 약한 소거활성을 나타내었다.When extracted with chicken feet content of 10% (C1), cell viability was 123 to 106.7% at 9 to 40 mg/ml, and cell viability was 86.8% at 50 mg/ml, but it was excluded based on the color of the sample itself. . In terms of NO scavenging activity, the group treated with LPS alone showed higher scavenging abilities of 8.5 μM and 8.7 μM at 9 mg/ml and 10 mg/ml, compared to 29.3 μM, and it was judged that the scavenging activity was high. When extracted with chicken feet content of 20% (C2), cytotoxicity was 45.4 ~ 67.1% at 1.56 ~ 50 mg/ml, and NO scavenging ability was 41.5 ~ 77.8 μM at 1.56 ~ 50 mg/ml, LPS alone treatment group 37.7 μM There was no scavenging activity with higher NO production. When extracted with chicken feet content of 30% (C3), cytotoxicity was shown with 45.8 to 61.7% viability at 9 to 50 mg/ml, and 37.8 to 37.4 μM at 1.25 to 10 mg/ml, compared to 43.6 μM in the LPS-only treatment group. showed weak scavenging activity.

상술한 바와 같이, 복합 추출물에 대한 추출조건별 세포독성 및 NO 소거능을 측정한 결과, 온도조건 100℃, 시간조건 15시간, 닭발 함량 조건 10%에서 세포독성이 없고, NO 소거능이 높다는 결과를 얻었다.As described above, as a result of measuring the cytotoxicity and NO scavenging ability for each extraction condition for the composite extract, it was found that there was no cytotoxicity and high NO scavenging ability under the temperature condition of 100 ° C, time condition of 15 hours, and chicken feet content condition of 10%. .

따라서, 복합 추출물의 제조시 닭발함량 10%, 추출시간 15시간, 추출 온도 100℃를 추출 조건으로 하여 제조할 때 항산화 효능 및 항염증 효능이 가장 좋은 것으로 나타났으며, 본 발명은 이러한 최적 추출 조건으로 복합 추출물을 추출하여 제조할 수 있다.Therefore, when preparing the composite extract, it was found that the antioxidant and anti-inflammatory effects were the best when the extract was prepared with 10% chicken feet content, 15 hours of extraction time, and 100 ° C. extraction temperature, and the present invention It can be prepared by extracting the complex extract with

한편, 본 발명은 복합 추출물의 제조시 복합 추출물을 항산화 및 항염증 효능을 향상시킬 수 있는 다양한 한약재를 고려하였으며, 이러한 한약재들 중에서 오가피와 두충을 선택한 근거를 실험을 통해 확인하였다.On the other hand, the present invention considered various herbal medicines that can improve the antioxidant and anti-inflammatory efficacy of the composite extract in the preparation of the composite extract, and confirmed the basis for selecting the Chinese herbal medicine and Eucommia chinensis among these herbal medicines through experiments.

이를 위해, 도 11에 도시된 바와 같이, 음료 조성물의 제조를 위한 이용 대상인 한약재로 오가피, 두충, 황칠, 황기 및 우슬을 선택하였으며, 오가피, 두충, 황칠, 황기 및 우슬 5가지 한약재를 1:1 비율로 교차 혼합하여 서로 다른 복수의 한약재 추출물을 추출하였다.To this end, as shown in Figure 11, five kinds of herbal medicines, Eucommia, Hwangchil, Astragalus, and Useul were selected as herbal medicines to be used for the preparation of beverage compositions, and five herbal medicines were 1: 1. A plurality of different herbal medicine extracts were extracted by cross-mixing at a ratio.

또한, 2가지 원료 500g씩 한약재 총 1kg에 정제수 10L를 가하여 100℃에서 15시간 추출하여 여과망을 통해 1차 여과 실시 후 여과지(Advantec No. 2, Toyo Roshi Kaisha Ltd., Tokyo, Japan)로 2차 여과하여 실험에 사용하였다.In addition, 10L of purified water was added to a total of 1kg of herbal medicines, 500g of each of the two raw materials, extracted at 100 ° C for 15 hours, and the first filtration was performed through a filter net, and the second It was filtered and used in the experiment.

도 12는 5가지 한약재를 각각 1:1로 혼합한 복수의 서로 다른 한약재 추출물의 총 페놀 및 플라보노이드 화합물 함량을 분석한 결과이다.Figure 12 is a result of analyzing the total phenolic and flavonoid compound contents of a plurality of different herbal medicinal extracts obtained by mixing 5 herbal medicinal materials at a ratio of 1:1.

총 페놀화합물의 함량은 Folin-Ciocalteu법(Gutfinger, 1958)으로 측정하였다. 시료 500 ㎕과 25% Na2CO3용액 500㎕을 혼합하여 3분간 정치시켰다. 다시 2 N-Folin-Ciocalteu phenol 시약 250㎕을 첨가하여 혼합한 다음 30℃에서 1시간 동안 정치시켜 발색시켰다. 발색된 청색을 분광광도계를 이용하여 750nm에서 흡광도를 측정하였다. 이때 총 폴리페놀 화합물의 함량은 gallic acid(Sigma-Aldrich Co., Ltd.,)를 이용하여 작성한 표준곡선으로부터 산출하였다.The content of total phenolic compounds was measured by the Folin-Ciocalteu method (Gutfinger, 1958). 500 μl of the sample and 500 μl of a 25% Na 2 CO 3 solution were mixed and allowed to stand for 3 minutes. Again, 250 μl of 2 N-Folin-Ciocalteu phenol reagent was added and mixed, and then allowed to stand at 30° C. for 1 hour to develop color. Absorbance of the developed blue color was measured at 750 nm using a spectrophotometer. At this time, the content of total polyphenol compounds was calculated from a standard curve prepared using gallic acid (Sigma-Aldrich Co., Ltd.,).

플라보노이드 함량은 시료액 500㎕에 1N NaOH 10㎕를 넣고 diethylene glycol 1 mL를 혼합하여 vortexing 한 후 37℃ 인큐베이터에서 45분간 반응시킨 후 420nm에서 흡광도를 측정하였다. 이 때 표준물질로 rutin(Sigma Co., Ltd., St. Louis, MO, USA)을 표준물질로 하여 얻은 검량선으로부터 총 플라보노이드 함량을 계산하였다.For the flavonoid content, 10 μl of 1N NaOH was added to 500 μl of the sample solution, mixed with 1 mL of diethylene glycol, vortexed, reacted in an incubator at 37 ° C for 45 minutes, and absorbance was measured at 420 nm. At this time, the total flavonoid content was calculated from a calibration curve obtained using rutin (Sigma Co., Ltd., St. Louis, MO, USA) as a standard material.

도시된 바와 같이, 총 페놀 화합물의 함량은 16.27 ~ 58.95 mg/g으로 한약재의 혼합에 따라 차이가 있었으며, 총 플라보노이드의 함량도 0 ~ 1.26 mg/g의 범위로 동일한 경향이었다. 또한, 총 페놀 함량 및 총 플라보노이드 함량을 종합적으로 고려하였을 때, 오가피와 두충을 혼합한 한약재 추출물이 가장 높게 나타나는 것으로 나타났다.As shown, the total phenolic compound content was 16.27 ~ 58.95 mg / g, which was different depending on the mixture of herbal medicines, and the total flavonoid content also had the same tendency in the range of 0 ~ 1.26 mg / g. In addition, when the total phenol content and the total flavonoid content were comprehensively considered, the herbal medicine extract mixed with Eucalyptus chinensis was found to be the highest.

또한, 한약재 추출물의 항염증 효능 검증을 세포실험에서 확인하기 위하여, 마우스 대식세포인 RAW 264.7 세포를 이용하여 세포독성 실험을 진행하였으며, 이에 대한 실험 결과는 도 13에 도시된 바와 같다.In addition, in order to confirm the anti-inflammatory efficacy of herbal extracts in cell experiments, cytotoxicity experiments were conducted using RAW 264.7 cells, which are mouse macrophages, and the experimental results are shown in FIG. 13.

도시된 바와 같이, 한약재 5가지를 5:5 비율별로 세포독성을 측정한 결과, 오가피와 두충의 경우 시료 자체의 진한 색으로 인해 고농도의 20 mg/ml 농도에서의 세포생존율은 시료자체 색에 의한 O.D 값으로 판단하였고, 황기의 경우 찌꺼기로 인해 정확한 결과 판단이 어려웠다. 오가피:두충(AB)의 경우 0.625 ~ 10 mg/ml에서 113.2 ~ 77.1%의 세포생존율을 나타내었다. 20 mg/ml에서 120%의 세포생존율을 나타내었지만 시료의 진한 색으로 인한 O.D 값으로 판단되었다. 오가피:황칠(AC)의 경우 0.625 mg/ml, 1.25 mg/ml에서 77.7%, 89%의 생존율을 보였지만 2.5 mg/ml, 5 mg/ml에서는 56.9%, 48%의 세포독성을 나타내었다. 10 mg/ml, 20 mg/ml에서는 83.5%, 120%의 생존율을 나타내었으나 고농도의 진한 색으로 인한 값으로 판단하였다. 오가피:황기(AD)의 경우 0.625 ~ 5 mg/ml에서 92.2 ~ 126%의 생존율을 나타내었으나 10 mg/ml에서 64.4%의 세포독성을 나타내었고, 20 mg/ml에서는 106.7%의 세포생존율을 나타내었으나 고농도의 진한색에의한 값으로 제외하였다. 오가피:우슬(AE)의 경우 0.625 ~ 5 mg/ml에서 111 ~ 120.3%의 세포생존율을 나타내었지만, 10 mg/ml에서 63.6%의 세포독성을 나타내었고 20 mg/ml에서 103%의 세포생존율을 나타내었지만 고농도의 진한 색으로 인해 제외하였다. 두충:황칠(BC)의 경우 0.625 mg/ml, 1.25 mg/ml에서 83.3%, 96.3%의 세포생존율을 나타내었지만, 2.5 mg/ml, 5 mg/ml에서 60.3%, 49.9%의 세포독성을 나타내었다. 두충:황기(BD)의 경우 0.625 ~ 20 mg/ml에서 118.3 ~ 94.9%의 세포생존율을 나타내었지만 황기의 시료에 있는 찌꺼기로 인해 정확한 결과 판단이 어렵다. 두충:우슬(BE)의 경우 0.625 ~ 20 mg/ml에서 110.9 ~ 94.9%의 세포생존율을 나타내었지만 고농도에서의 생존율은 제외하였다. 황칠:황기(CD)의 경우 0.625 ~ 2.5 mg/ml에서 78.7 ~ 75.6%의 세포생존율을 나타내었고, 5 mg/ml, 10 mg/ml에서 47.4%, 41.8%의 세포독성을 보였다. 황칠:우슬(CE)의 경우 0.625 ~ 2.5 mg/ml에서 88.8 ~ 81.2%의 세포생존율을 나타내었지만 5 mg/ml, 10 mg/ml에서 49.8%, 52.3%의 세포독성을 나타내었다. 황기:우슬(DE)의 경우 0.625 ~ 20 mg/ml에서 109.4 ~ 103.2%의 세포생존율을 나타내었지만 고농도의 세포생존율은 제외하였다.As shown, as a result of measuring the cytotoxicity of 5 kinds of herbal medicines at a ratio of 5:5, in the case of cucumber and Eucommia, due to the dark color of the sample itself, the cell viability at a high concentration of 20 mg/ml was due to the color of the sample itself. It was judged by the O.D value, and in the case of astragalus, it was difficult to accurately judge the result due to the residue. In the case of Ogapi: Eucommia (AB), the cell viability was 113.2 ~ 77.1% at 0.625 ~ 10 mg/ml. Although cell viability of 120% was shown at 20 mg/ml, it was judged as an O.D value due to the dark color of the sample. In the case of Ogapi: Hwangchil (AC), viability rates were 77.7% and 89% at 0.625 mg/ml and 1.25 mg/ml, but cytotoxicity was 56.9% and 48% at 2.5 mg/ml and 5 mg/ml, respectively. At 10 mg/ml and 20 mg/ml, survival rates of 83.5% and 120% were shown, but the value was judged to be due to the high concentration of dark color. Astragalus astragalus (AD) showed 92.2 to 126% of viability at 0.625 to 5 mg/ml, but 64.4% of cytotoxicity at 10 mg/ml and 106.7% of cell viability at 20 mg/ml. However, it was excluded due to the value due to the high concentration of dark color. In the case of Ogapi:usul (AE), cell viability was 111 to 120.3% at 0.625 to 5 mg/ml, but cytotoxicity was 63.6% at 10 mg/ml and cell viability was 103% at 20 mg/ml. However, it was excluded due to the dark color of high concentration. Eucommia: Hwangchil (BC) showed cell viability of 83.3% and 96.3% at 0.625 mg/ml and 1.25 mg/ml, but showed cytotoxicity of 60.3% and 49.9% at 2.5 mg/ml and 5 mg/ml was Eucommia: Astragalus (BD) showed cell viability of 118.3 to 94.9% at 0.625 to 20 mg/ml, but it is difficult to accurately determine the result due to the residue in the Astragalus sample. Eucommia:usul (BE) showed cell viability of 110.9 ~ 94.9% at 0.625 ~ 20 mg/ml, but the survival rate at high concentration was excluded. Hwangchil: Hwangchil (CD) showed cell viability of 78.7 ~ 75.6% at 0.625 ~ 2.5 mg/ml, and cytotoxicity of 47.4% and 41.8% at 5 mg/ml and 10 mg/ml. In the case of hwangchil:usul (CE), cell viability was 88.8 to 81.2% at 0.625 to 2.5 mg/ml, but cytotoxicity was 49.8% and 52.3% at 5 mg/ml and 10 mg/ml. Astragalus:usul (DE) showed cell viability of 109.4 to 103.2% at 0.625 to 20 mg/ml, but high concentration cell viability was excluded.

상술한 바와 같이, 오가피와 두충을 이용한 한약재 추출물에서 항산화 및 항염증 효능이 높게 나타나는 것으로 판단된다.As described above, it is judged that the antioxidant and anti-inflammatory effects are high in the herbal medicine extracts using oleracea and Eucommia.

상술한 바에 따라, 본 발명은 닭발을 이용한 음료 조성물을 제조하여 닭발이 가진 항산화 및 항염증 효능을 가진 닭발 고유의 영양 성분을 닭발 자체에 대한 거부감이 있는 사람도 음료 형태로 편리하고 용이하게 섭취할 수 있도록 지원함과 아울러 닭발의 항산화 및 항염증 효능을 높여주는 한약재를 닭발과 혼합하여 음료 조성물을 제조함으로써, 한약재를 통해 닭발 특유의 냄새를 잡아주어 닭발을 이용한 음료의 기호도를 높이면서 닭발의 항산화 및 항염증 효능을 더욱 높여주는 음료를 제공할 수 있다.As described above, the present invention prepares a beverage composition using chicken feet, so that even those who are reluctant to chicken feet themselves can conveniently and easily consume the nutritional components unique to chicken feet, which have antioxidant and anti-inflammatory effects, in the form of a beverage. In addition, by mixing herbal medicines that enhance the antioxidant and anti-inflammatory effects of chicken feet with chicken feet to prepare a beverage composition, the herbal medicine captures the unique smell of chicken feet, increasing the preference of drinks using chicken feet, while increasing the antioxidant and anti-oxidation properties of chicken feet. A beverage that further enhances the anti-inflammatory effect can be provided.

Claims (5)

닭발의 핏물을 제거하는 제거 단계;
상기 닭발을 10 ~ 20분간 데치는 데침 단계;
상기 데침 단계를 거친 닭발, 정제수, 오가피 및 두충을 혼합하여 제조된 혼합물을 100℃에서 15 시간 열수 추출하여 복합 추출물을 얻는 추출 단계; 및
상기 복합 추출물을 여과하여 음료 조성물을 제조하는 여과 단계를 포함하되,
상기 추출 단계는,
상기 혼합물의 전체 중량 비율 중 상기 닭발이 차지하는 중량 비율이, 세포 독성에서 안전한 함유량이 되도록 10 중량%로 하여 상기 혼합물을 제조하는 단계와,
상기 오가피와 두충을 각각 2 ~ 4 중량%에서 1:1 비율로 혼합하여 열수 추출 시 플라보노이드와 페놀화합물 함량이 각각 50mg/g, 1.2mg/g 이상이 되도록 하면서 20 mg/ml 이하에서 77.1~120%의 세포 생존율을 유지하도록 하는 단계와,
상기 혼합물의 세포 독성을 낮추기 위하여 추출 온도를 100℃로 하고, 추출 시간을 15 시간으로 한정하여 열수 추출을 하는 것으로 상기 복합 추출물을 얻는 단계를 포함하며,
상기 추출 단계는,
상기 정제수 70 ~ 80 중량%, 상기 데침 단계를 거친 닭발 10 중량%, 상기 오가피 2 ~ 4 중량%, 상기 두충 2 ~ 4 중량% 및 감미료 6 ~ 10 중량% 혼합하여 상기 혼합물을 제조하고,
상기 감미료는 대추, 생강, 옥수수염, 꿀, 오미자액으로 구성되는 것을 특징으로 하는 닭발과 한약재를 이용한 음료 조성물의 제조 방법.
A removal step of removing blood from chicken feet;
A blanching step of blanching the chicken feet for 10 to 20 minutes;
An extraction step of obtaining a composite extract by hot water extraction of the mixture prepared by mixing the blanched chicken feet, purified water, cucumber skin and Eucommia at 100 ° C. for 15 hours; and
Including a filtration step of preparing a beverage composition by filtering the complex extract,
The extraction step is
Preparing the mixture so that the weight ratio of the chicken feet in the total weight ratio of the mixture is 10% by weight so that the content is safe from cytotoxicity;
By mixing the above cucumbers and Eucommia at 2 to 4% by weight in a 1: 1 ratio, the content of flavonoids and phenolic compounds is 50 mg/g and 1.2 mg/g or more during hot water extraction, respectively, and 77.1 to 120 at 20 mg/ml or less. maintaining % cell viability;
In order to lower the cytotoxicity of the mixture, the extraction temperature is set to 100 ° C. and the extraction time is limited to 15 hours to obtain the complex extract by performing hot water extraction,
The extraction step is
70 to 80% by weight of the purified water, 10% by weight of chicken feet subjected to the blanching step, 2 to 4% by weight of the cucumber skin, 2 to 4% by weight of the Eucommia worm, and 6 to 10% by weight of a sweetener are mixed to prepare the mixture,
The sweetener is a method for producing a beverage composition using chicken feet and herbal medicine, characterized in that consisting of jujube, ginger, corn salt, honey, and Schizandra chinensis.
삭제delete 삭제delete 삭제delete 삭제delete
KR1020200048506A 2020-04-22 2020-04-22 Method for manufacturing beverage composition using chicken feet and herbal medicine KR102472612B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020200048506A KR102472612B1 (en) 2020-04-22 2020-04-22 Method for manufacturing beverage composition using chicken feet and herbal medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020200048506A KR102472612B1 (en) 2020-04-22 2020-04-22 Method for manufacturing beverage composition using chicken feet and herbal medicine

Publications (2)

Publication Number Publication Date
KR20210130383A KR20210130383A (en) 2021-11-01
KR102472612B1 true KR102472612B1 (en) 2022-11-30

Family

ID=78519061

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020200048506A KR102472612B1 (en) 2020-04-22 2020-04-22 Method for manufacturing beverage composition using chicken feet and herbal medicine

Country Status (1)

Country Link
KR (1) KR102472612B1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100434874B1 (en) * 2001-09-29 2004-06-07 주식회사 정생선로 Extract and Extracting method from Ogol fowl
KR101397189B1 (en) * 2012-07-12 2014-05-19 박주환 extraction beverage and manufacturing method thereof
KR101401031B1 (en) 2014-02-24 2014-05-29 (주)숲풀림식품 Method for preparing a food using chicken foot

Also Published As

Publication number Publication date
KR20210130383A (en) 2021-11-01

Similar Documents

Publication Publication Date Title
KR100472052B1 (en) Cosmetic composition using fermentation of natural herb medicine
KR101231962B1 (en) Dressing and process thereof
KR102078461B1 (en) Food additives
JP2009013146A (en) Diabetes treating composition
KR20120079943A (en) Powder sauce and process thereof
KR101256744B1 (en) Hot sauce and process thereof
KR20210068967A (en) Composition for relieving and preventing hangover comprising dendropanax morbifera extract
KR101264245B1 (en) Functional fermented food for improvement of gout
KR101256739B1 (en) Mixed sauce and process thereof
KR101139064B1 (en) Produce Sweet Salt ? Edible Vita oil Contain The Seaweed
KR102250474B1 (en) Functional rice cake with cancer preventive effect and method for producing the same
KR101245345B1 (en) Germinated brown rice for prevention of obesite and method of production thereof
KR102472612B1 (en) Method for manufacturing beverage composition using chicken feet and herbal medicine
KR101182039B1 (en) The Chinese matrimony vine & Leaf Gochujang
KR101512230B1 (en) Arthritis Remedy Composition and manufacture method having immunity and the circulation of the blood improvement fuction
KR20130070065A (en) Functional herbal food and method for production thereof
KR20080033717A (en) Health assistance food composition using honey and crude drugs and the making method
KR20100035464A (en) Medical crops bun and the manufacturing method thereof
KR102215936B1 (en) Functional Food Composition Ssangwhatang for Fatigue Recovery comprising Chestnut and Manufacturing method of thereof
KR101488589B1 (en) pill manufacture method using palm tree fruit
KR101381277B1 (en) The wild rice gel containing ginseng
KR101800787B1 (en) The manufacturing method of ginseng dried radish leaf rice
KR100894738B1 (en) Health supplement food using salicornia herbacea l. and health supplement food thereof
KR20160010909A (en) Natural beauty soap for the improvement and treatment of the Eczema.acne, psoriasis, seborrheic skin using White Ionic Minerals, SY2220, and White Ionic Minerals distilled water, SY2216, extracted from white clay of Yang Gu Bangsan region and manufacturing method and that compositions.
KR102489041B1 (en) Production method of low salt napa cabbage kimchi using functional spice

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
X701 Decision to grant (after re-examination)